BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Clinical Trials

Odyssey Group Approved to Start Human Trial to Treat Concussion

The Company’s Clinical Trial Protocol was approved by the Alfred Ethics Committee and allows for the immediate start of the human trial. “We a...

September 08, 2021 | News

Stem Cells for Everyone: I Peace expands its clinical-grade

I Peace, Inc. (CEO: Koji Tanabe, https://ipeace.com/), a Palo Alto-based biotech startup focusing on Nobel Prize-winning technology of ...

September 08, 2021 | News

NuProbe Enables Rapid Ultrasensitive Mutation Detection

he method, termed oncogene concatenated enriched amplicon nanopore sequencing (OCEANS), enables rapid, accurate, and affordable detection of somatic mutati...

September 07, 2021 | News

CSL Behring Underscores its Commitment to Respiratory Patients with Strong Focus on Research

Focusing on what we have learnt about the impact of global Covid-19 pandemic on pulmonary disease research, it will also explore the latest updates in the ...

September 06, 2021 | News

Pfizer Starts PhIII Clinical Trial in Adults for Its Vaccine Against Respiratory Syncytial Virus (RSV)

Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV disease), a...

September 02, 2021 | News

Cough monitoring smartphone app incorporated into year-long respiratory research trial

Hyfe, a cough monitoring smartphone app and digital diagnostics tool developed by an international team of scientists and public health professionals, rece...

August 31, 2021 | News

Senhwa's Silmitasertib Receives US FDA Fast Track Designation

Senhwa Biosciences, Inc., a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today ann...

August 19, 2021 | News

Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy

Terumo Blood and Cell Technologies (Terumo), a medical device company specializing in a portfolio of technology, software and services for blood...

August 12, 2021 | News

New Zealand approved YishengBio COVID-19 vaccine trials

YishengBio is a biopharmaceutical company focusing on discovery, development, manufacturing and commercialization of new generations of vaccines and therap...

August 10, 2021 | News

Clarivate Acquires Bioinfogate

Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customer...

August 05, 2021 | News

Insilico ,Westlake to jointly develop innovative small-molecule drugs for COVID19

The cooperation will be based on the anti-COVID-19 drug R&D project by Westlake Pharma, which aims to develop broad-spectrum small molecule inhibitor d...

August 03, 2021 | News

Bharat Biotech’s ROTAVAC 5D® Receives WHO Prequalification

Prequalification will fast-track procurement and global access of ROTAVAC 5D® · &nbs...

August 02, 2021 | News

BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines

Earlier, BIOKANGTAI has already been approved by the Vaccine Expert Panel (VEP) of the Philippine Department of Science and Technology (DOST) on June ...

August 02, 2021 | News

Clarity commences theranostic prostate cancer trial

Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...

July 29, 2021 | News

Stay Connected